Literature DB >> 14657662

Cdk2 as a master of S phase entry: fact or fake?

Eiman Aleem1, Cyril Berthet, Philipp Kaldis.   

Abstract

It has long been believed that Cdk2 and its activator cyclin E play essential roles in the progression of the mitotic cell cycle. However, recent studies using knockout mouse models revealed that neither Cdk2 nor cyclin E are essential in vivo. The purpose of this Perspective is to compare both Cdk2 and cyclin E knockout mice models and to discuss potential mechanisms driving the cell cycle in the absence of Cdk2 or cyclin E. Particular emphasis is placed on possible non-catalytic roles of cyclin E, the expression and activity of the second cyclin binding partner of Cdk2, cyclin A, as well as on the expression and degradation of the Cdk2 inhibitor p27Kip1 in the absence of Cdk2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14657662

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

Review 1.  Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy.

Authors:  Agnieszka K Witkiewicz; Vishnu Kumarasamy; Ioannis Sanidas; Erik S Knudsen
Journal:  Trends Cancer       Date:  2022-05-20

2.  A novel binding pocket of cyclin-dependent kinase 2.

Authors:  Hao Chen; Rachel Van Duyne; Naigong Zhang; Fatah Kashanchi; Chen Zeng
Journal:  Proteins       Date:  2009-01

3.  Cdk2 catalytic activity is essential for meiotic cell division in vivo.

Authors:  Sangeeta Chauhan; M Kasim Diril; Joanna H S Lee; Xavier Bisteau; Vanessa Manoharan; Deepak Adhikari; Chandrahas Koumar Ratnacaram; Baptiste Janela; Juliane Noffke; Florent Ginhoux; Vincenzo Coppola; Kui Liu; Lino Tessarollo; Philipp Kaldis
Journal:  Biochem J       Date:  2016-07-01       Impact factor: 3.857

4.  Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.

Authors:  Alexandra L Thomas; Hanne Lind; Angela Hong; Danijela Dokic; Kailey Oppat; Elana Rosenthal; Amina Guo; Aaron Thomas; Randala Hamden; Jacqueline S Jeruss
Journal:  Cell Cycle       Date:  2017-07-05       Impact factor: 4.534

5.  A general framework for modeling growth and division of mammalian cells.

Authors:  John H Gauthier; Phillip I Pohl
Journal:  BMC Syst Biol       Date:  2011-01-06

6.  Tanshinone IIA Inhibits Growth of Keratinocytes through Cell Cycle Arrest and Apoptosis: Underlying Treatment Mechanism of Psoriasis.

Authors:  Fu-Lun Li; Rong Xu; Qing-Chun Zeng; Xin Li; Jie Chen; Yi-Fei Wang; Bin Fan; Lin Geng; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-16       Impact factor: 2.629

7.  Phosphorylation of human DNA polymerase lambda by the cyclin-dependent kinase Cdk2/cyclin A complex is modulated by its association with proliferating cell nuclear antigen.

Authors:  Isabelle Frouin; Magali Toueille; Elena Ferrari; Igor Shevelev; Ulrich Hübscher
Journal:  Nucleic Acids Res       Date:  2005-09-20       Impact factor: 16.971

8.  Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.

Authors:  Tomáš Kyca; Lucia Pavlíková; Viera Boháčová; Anton Mišák; Alexandra Poturnayová; Albert Breier; Zdena Sulová; Mário Šereš
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

9.  An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.

Authors:  Nobuyoshi Sugaya; Kazuyoshi Ikeda; Toshiyuki Tashiro; Shizu Takeda; Jun Otomo; Yoshiko Ishida; Akiko Shiratori; Atsushi Toyoda; Hideki Noguchi; Tadayuki Takeda; Satoru Kuhara; Yoshiyuki Sakaki; Takao Iwayanagi
Journal:  BMC Pharmacol       Date:  2007-08-20

10.  YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Authors:  Erica Lorenzetto; Monica Brenca; Mattia Boeri; Carla Verri; Elena Piccinin; Patrizia Gasparini; Federica Facchinetti; Sabrina Rossi; Giuliana Salvatore; Maura Massimino; Gabriella Sozzi; Roberta Maestro; Piergiorgio Modena
Journal:  Oncotarget       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.